Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06636058 · ClinicalTrials.gov registry record · NA

Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

A NA study of Obesity and Depression, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
440
Enrollment target
2
Study locations

NCT06636058: Recruiting NA study of Obesity and Depression, sponsored by University of Illinois at Chicago.

NCT06636058 is a NA study of Obesity and Depression that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 440 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (46% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06636058, a NA study of Obesity and Depression, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
2
Study locations

Study Summary

The goal of this randomized clinical trial is to test the efficacy of a fully digital intervention, combining the Lumen problem-solving therapy virtual coach for depression management with the Diabetes Prevention Program video-based program for weight loss, among racial and ethnic minorities with comorbid depression and obesity. The study aims include: * Determine the efficacy of the vCare intervention at 6 months. Primary outcomes are weight and depression symptom checklist 20-item (SCL-20) score. * Identify predictors of treatment success, defined by achieving clinically significant weight loss (5%) and depression outcomes (50% decline or SCL-20\<0.5), at 6 and 12 months. * Characterize participant experiences and perceptions of the vCare intervention. Eligible participants will be randomized to the early-intervention arm who will receive active treatment for 6 months, followed by maintenance for another 6 months, or the later-intervention arm who will be waitlisted for 6 months and then receive active treatment in the second 6 months.

Primary Outcome

All participants will receive a study-provided wireless weight scale (Withings Body - Digital Wi-Fi Smart Scale), assistance with account and device setup, and as-needed tech support. A study coordinator who is blinded to randomization will proactively contact participants by phone, email, and/or text to remind them to weigh themselves in the morning after urination (and a bowel movement too, if able to do so) on 3 days during the assessment week at baseline (0), 6, 12 months. Participants will

Conditions Studied

Interventions

  • BEHAVIORAL vCare Intervention (6-month active treatment followed by 6-month maintenance)
  • BEHAVIORAL vCare Intervention (active treatment after 6 months)

Study Locations (2)

Illinois

  • Department of Medicine, Vitoux Program on Aging and Prevention - Chicago

Missouri

  • Washington University School of Medicine in St Louis - St Louis

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2025-01-21
Est. Completion 2028-10-13
Phase NA
University of Illinois at Chicago

430 total trials

What NCT06636058 shows while recruiting

NCT06636058 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (46% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which vCare Intervention (6-month active treatment followed by 6-month maintenance) is the first listed.

NCT06636058 reports a single indexed study location in Illinois, Missouri.

Frequently Asked Questions

What is clinical trial NCT06636058 about?

NCT06636058 is a clinical study titled "Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older". The goal of this randomized clinical trial is to test the efficacy of a fully digital intervention, combining the Lumen problem-solving therapy virtual coach for depression management with the Diabetes Prevention Program video-based program for weight loss, among racial and ethnic minorities with co...

What is the current status of trial NCT06636058?

This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2025-01-21. Estimated completion is 2028-10-13.

What conditions does trial NCT06636058 study?

This clinical trial studies the following conditions: Obesity, Depression.

What interventions are being tested in trial NCT06636058?

The interventions under investigation include: vCare Intervention (6-month active treatment followed by 6-month maintenance) (BEHAVIORAL), vCare Intervention (active treatment after 6 months) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06636058?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06636058 being conducted?

This trial has 2 study locations across Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06636058's enrollment target sits among peer trials

440 155th of 1053 higher than 898 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

  • NCT05117619 · 440 participants · NA

    The HOME Program for Individuals With Traumatic Brain Injury and Family Members

  • NCT05602194 · 440 participants · Phase 3

    Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

  • NCT05624879 · 440 participants · NA

    Accelerated Resolution Therapy for Early Maladaptive Grief

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06636058, the US trial registry maintained by the National Library of Medicine. NCT06636058 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.